Stone Toro Investment Advisers’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Stone Toro Investment Advisers’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-36,000	Closed	-$610K	–	99
2014 Q4	$610K	Buy	+36,000	New	+$506K	1.58%	20

Stone Toro Investment Advisers's AVNR Position: Q1 2015 in Review

Stone Toro Investment Advisers sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 36,000 shares — an estimated $610K sold.

Stone Toro Investment Advisers first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $610K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Stone Toro Investment Advisers reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Stone Toro Investment Advisers sold 36,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $610K.
Stone Toro Investment Advisers first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Stone Toro Investment Advisers's AVANIR PHARMACEUTICALS, INC CL A position peaked at $610K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Stone Toro Investment Advisers's 13F filing for Q1 2015, filed 7 May 2015.